Citation data

OpenCitations

Works that cite this article, indexed by OpenCitations.

15 resultsUpdated October 20, 2026
1

Review: Approved Heterocycles Based Antiviral Drugs

International Journal of Scientific Research in Science and Technology 12(4) (2025)

Adinath. D. Badar; Pramod. S. Phatak

3

IRMPD action spectroscopy, ER-CID experiments, and theoretical approaches investigate intrinsic L-thymidine properties compared to D-thymidine: Findings support robust methodology

International Journal of Mass Spectrometry 441 (2019)

Erik O. Soley; Zachary J. Devereaux; L.A. Hamlow; G. Berden; J. Oomens; M.T. Rodgers

4

Baseline Hepatitis B Virus Titer Predicts Initial Postpartum Hepatic Flare

Journal of Clinical Gastroenterology 52(10) (2018)

Jinfeng Liu; Jing Wang; Caijing Qi; Furong Cao; Zhen Tian; Dandan Guo; Taotao Yan; Qian Li; Shujuan Yang; JianJun Fu; Xianmei Tang; Xiaoni Kou; Na Liu; Zicheng Jiang; Yingren Zhao; Tianyan Chen

5

Effect of Telbivudine Versus Other Nucleos(t)ide Analogs on HBeAg Seroconversion and Other Outcomes in Patients with Chronic Hepatitis B: A Network Meta-Analysis

Advances in Therapy 33(4) (2016)

Xieer Liang; Rong Fan; Jian Sun; Javed Shaikh; Ankush Taneja; Subhajit Gupta; Kamal Hamed

6

Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan

Hepatology International 10(2) (2015)

Chia-Chi Wang; Chih-Lin Lin; Tsai-Yuan Hsieh; Kuo-Chih Tseng; Cheng-Yuan Peng; Tung-Hung Su; Sheng-Shun Yang; Yu-Chun Hsu; Tsung-Ming Chen; Jia-Horng Kao

7

Comprehensive analysis of hospital-based prospective cohort reveals the unique effectiveness and safety for nucleos(t)ide analogues in HBV patients

Clinics and Research in Hepatology and Gastroenterology 40(2) (2016)

Yuankai Wu; Yusheng Jie; Xiangyong Li; Mingxing Huang; Xinhua Li; Hong Shi; Shuru Chen; Min Zhang; Yunlong Ao; Fangji Yang; Zhiliang Gao; Guoli Lin; Yutian Chong

9

Telbivudine therapy for chronic hepatitis B: A journey to identify super‐responders and to optimize treatment using the roadmap model

Journal of Gastroenterology and Hepatology 32(1) (2017)

Jia‐Horng Kao; Tarik Asselah; Xiao‐Guang Dou; Kamal Hamed

10

Approved Antiviral Drugs over the Past 50 Years

Clinical Microbiology Reviews 29(3) (2016)

Erik De Clercq; Guangdi Li

11

Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification

Yonsei Medical Journal 59(3) (2018)

Jong Won Choi; Se Hyun Kim; Jeong Hun Seo; Yong Suk Cho; Sun Young Won; Byung Kyu Park; Han Ho Jeon; Yong Kang Lee; Chun Kyon Lee

12

Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels

Journal of Cellular Biochemistry 120(4) (2018)

Jing‐Ya Yan; Zhi‐Qin Li; Zu‐Jiang Yu; Quan‐Chen Kan

13

Bayesian Network Meta-Analysis for Assessing Adverse Effects of Anti-hepatitis B Drugs

Clinical Drug Investigation 39(9) (2019)

Yi Shen; Yulong Jia; Jie Zhou; Juling Ji; Pengcheng Xun

14

Adverse effects of oral antiviral therapy in chronic hepatitis B

World Journal of Hepatology 9(5) (2017)

Bircan Kayaaslan; Rahmet Guner